HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Botox off-label use as anti-wrinkle treatment discussed by MDs at AAD annual meeting.

This article was originally published in The Rose Sheet

Executive Summary

BOTOX OFF-LABEL ANTI-WRINKLE USE discussed by dermatologist Nicholas Lowe, MD, University of California at Los Angeles at the American Academy of Dermatology annual meeting held in San Francisco in March. "In carefully administered low doses," the prescription drug Botox "is very useful for treating hyperkinetic facial lines," Lowe said in a March 21 press release issued by AAD.
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS004008

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel